News & Updates
Filter by Specialty:
Immunosuppressant exposure tied to guideline-congruent cervical cancer screening
Guideline-congruent screening for cervical cancer remains poor in women with systemic lupus erythematosus (SLE), according to a study.
Immunosuppressant exposure tied to guideline-congruent cervical cancer screening
24 Nov 2022
Anifrolumab for SLE shows favourable benefit–risk profile in extension study
Patients with moderate-to-severe systemic lupus erythematosus (SLE) appear to fare well with anifrolumab, with a recent study showing that the drug has an acceptable long-term safety profile and helps maintain reductions in disease activity and glucocorticoid usage.
Anifrolumab for SLE shows favourable benefit–risk profile in extension study
22 Nov 2022
Inflammatory bowel disease may cause psoriasis, psoriatic arthritis
Inflammatory bowel disease appears to be a causal risk factor for both psoriasis and psoriatic arthritis, with Crohn’s disease specifically associated with the development of the two psoriasis outcomes, according to a study.
Inflammatory bowel disease may cause psoriasis, psoriatic arthritis
22 Nov 2022
Tocilizumab trumps etanercept at suppressing RA joint erosion
Treatment with tocilizumab leads to better suppression of joint erosion progression as compared to etanercept in patients with rheumatoid arthritis (RA), reports a recent study.
Tocilizumab trumps etanercept at suppressing RA joint erosion
25 Oct 2022
Krill oil relieves pain in adults with knee osteoarthritis
Krill oil supplement is not only safe to consume but also modestly improves knee pain, stiffness, and physical function in adults with mild to moderate knee osteoarthritis (OA), reveals a study.
